Your browser doesn't support javascript.
loading
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.
Gu, Zhaohui; Churchman, Michelle L; Roberts, Kathryn G; Moore, Ian; Zhou, Xin; Nakitandwe, Joy; Hagiwara, Kohei; Pelletier, Stephane; Gingras, Sebastien; Berns, Hartmut; Payne-Turner, Debbie; Hill, Ashley; Iacobucci, Ilaria; Shi, Lei; Pounds, Stanley; Cheng, Cheng; Pei, Deqing; Qu, Chunxu; Newman, Scott; Devidas, Meenakshi; Dai, Yunfeng; Reshmi, Shalini C; Gastier-Foster, Julie; Raetz, Elizabeth A; Borowitz, Michael J; Wood, Brent L; Carroll, William L; Zweidler-McKay, Patrick A; Rabin, Karen R; Mattano, Leonard A; Maloney, Kelly W; Rambaldi, Alessandro; Spinelli, Orietta; Radich, Jerald P; Minden, Mark D; Rowe, Jacob M; Luger, Selina; Litzow, Mark R; Tallman, Martin S; Racevskis, Janis; Zhang, Yanming; Bhatia, Ravi; Kohlschmidt, Jessica; Mrózek, Krzysztof; Bloomfield, Clara D; Stock, Wendy; Kornblau, Steven; Kantarjian, Hagop M; Konopleva, Marina; Evans, Williams E.
Afiliación
  • Gu Z; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Churchman ML; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Roberts KG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Moore I; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Zhou X; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Nakitandwe J; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Hagiwara K; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Pelletier S; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Gingras S; Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
  • Berns H; Department of Transgenic/Gene Knockout Shared Resource, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Payne-Turner D; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Hill A; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Iacobucci I; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Shi L; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Pounds S; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Cheng C; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Pei D; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Qu C; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Newman S; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Devidas M; Department of Biostatistics, University of Florida, Gainesville, FL, USA.
  • Dai Y; Department of Biostatistics, University of Florida, Gainesville, FL, USA.
  • Reshmi SC; Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
  • Gastier-Foster J; Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
  • Raetz EA; Division of Pediatric Hematology-Oncology, New York University, New York, NY, USA.
  • Borowitz MJ; Division of Hematologic Pathology, Johns Hopkins University, Baltimore, MD, USA.
  • Wood BL; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
  • Carroll WL; Perlmutter Cancer Center, NYU-Langone Health, New York, NY, USA.
  • Zweidler-McKay PA; ImmunoGen, Inc, Waltham, MA, USA.
  • Rabin KR; Baylor College of Medicine, Houston, TX, USA.
  • Mattano LA; HARP Pharma Consulting, Mystic, CT, USA.
  • Maloney KW; University of Colorado School of Medicine and Children's Hospital, Aurora, CO, USA.
  • Rambaldi A; Hematology and Bone Marrow Transplant Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
  • Spinelli O; Hematology and Bone Marrow Transplant Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
  • Radich JP; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Minden MD; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Rowe JM; Hematology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Luger S; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Litzow MR; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Tallman MS; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Racevskis J; Cancer Center, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Zhang Y; Cytogenetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Bhatia R; Division of Hematology-Oncology, University of Birmingham, Birmingham, AL, USA.
  • Kohlschmidt J; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Mrózek K; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Bloomfield CD; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Stock W; University of Chicago Medical Center, Chicago, IL, USA.
  • Kornblau S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Evans WE; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
Nat Genet ; 51(2): 296-307, 2019 02.
Article en En | MEDLINE | ID: mdl-30643249
ABSTRACT
Recent genomic studies have identified chromosomal rearrangements defining new subtypes of B-progenitor acute lymphoblastic leukemia (B-ALL), however many cases lack a known initiating genetic alteration. Using integrated genomic analysis of 1,988 childhood and adult cases, we describe a revised taxonomy of B-ALL incorporating 23 subtypes defined by chromosomal rearrangements, sequence mutations or heterogeneous genomic alterations, many of which show marked variation in prevalence according to age. Two subtypes have frequent alterations of the B lymphoid transcription-factor gene PAX5. One, PAX5alt (7.4%), has diverse PAX5 alterations (rearrangements, intragenic amplifications or mutations); a second subtype is defined by PAX5 p.Pro80Arg and biallelic PAX5 alterations. We show that p.Pro80Arg impairs B lymphoid development and promotes the development of B-ALL with biallelic Pax5 alteration in vivo. These results demonstrate the utility of transcriptome sequencing to classify B-ALL and reinforce the central role of PAX5 as a checkpoint in B lymphoid maturation and leukemogenesis.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Factor de Transcripción PAX5 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Animals / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Factor de Transcripción PAX5 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Animals / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
...